Trials / Sponsors / Evotec Neurosciences GmbH
Evotec Neurosciences GmbH
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Phase II Study to Evaluate the Effectiveness of EVT 302 in Smoking Cessation. Smoking Cessation | Phase 2 | 2008-08-01 |
| Completed | Effects of EVT 302 With or Without NRT on Craving and Withdrawal in Healthy Male Smokers Deprived of Cigarette Smoking Cessation | Phase 2 | 2008-02-01 |
| Completed | The Effects of a Novel NMDA NR2B-Subtype Selective Antagonist, EVT 101, on Brain Function Human Volunteers | Phase 1 | 2007-09-01 |
| Completed | Efficacy Study of EVT 201 in the Treatment of Elderly Patients With Daytime Sleepiness Sleep Initiation and Maintenance Disorders | Phase 2 | 2006-11-01 |
| Completed | Efficacy Study of EVT 201 to Treat Insomnia Sleep Initiation and Maintenance Disorders | Phase 2 | 2006-09-01 |